Methylphenidate Orion

Methylphenidate hydrochloride, the active ingredient in Methylphenidate Orion, is a central nervous system stimulant presented as an oral dosage form for oral use. It is prescribed for the management of attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults, and is classified under ATC code N06BA04.

GNH USA supplies Methylphenidate Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, and supports timely patient access.

Methylphenidate Orion is a central nervous system stimulant used in the treatment of neurobehavioral disorders.

- Attention deficit hyperactivity disorder (ADHD) in children and adolescents: improves attention, reduces hyperactivity and impulsivity. - Attention deficit hyperactivity disorder (ADHD) in adults: enhances concentration and executive function. - Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.

Methylphenidate Orion may cause a range of adverse reactions.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced desire for food, potentially affecting weight. - Headache: mild to moderate cranial pain. - Stomach pain: abdominal discomfort or cramps.

Serious or Rare Side Effects: - Arrhythmia: irregular heart rhythm that may require medical attention. - Hypertension: elevated blood pressure potentially leading to cardiovascular risk. - Psychosis: emergence of hallucinations or delusional thoughts.

Before prescribing Methylphenidate Orion, clinicians should consider several safety measures.

- Assess cardiovascular status: evaluate blood pressure and heart rate before initiating therapy. - Monitor growth in children: track height and weight regularly during treatment. - Avoid use in patients with known hypersensitivity: discontinue if an allergic reaction occurs. - Use caution with concomitant MAO inhibitors: ensure an appropriate washout period to prevent interactions. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Methylphenidate Orion can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: may increase cardiovascular effects. - Antihypertensive agents: may reduce efficacy of blood pressure control.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may increase methylphenidate plasma levels. - Antacids: may affect absorption of the drug. - Alcohol: may exacerbate central nervous system stimulation.